Cell and Gene Therapy Manufacturing Services Market Size, Trends, Analysis, and Outlook By Type (Cell Therapy, Gene Therapy), By Indication (Oncology, Cardiovascular, Orthopedic, Ophthalmology, Central Nervous System, Infectious Diseases, Others), By Application (Clinical Manufacturing, Commercial Manufacturing), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
The global Cell and Gene Therapy Manufacturing Services market size is poised to register 22.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cell and Gene Therapy Manufacturing Services market across By Type (Cell Therapy, Gene Therapy), By Indication (Oncology, Cardiovascular, Orthopedic, Ophthalmology, Central Nervous System, Infectious Diseases, Others), By Application (Clinical Manufacturing, Commercial Manufacturing), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
The cell and gene therapy manufacturing services market is driven by the increasing investment in cell and gene therapy development, advancements in bioprocessing technologies, and the need for scalable and cost-effective manufacturing solutions. By 2030, the market is expected to witness significant growth, fueled by innovations in cell expansion systems, viral vector production platforms, and automated manufacturing processes. Further, expanding applications in personalized medicine, rare disease therapies, and cancer immunotherapies are anticipated to drive market expansion, enabling biopharmaceutical companies and contract development and manufacturing organizations (CDMOs) to accelerate the translation of cell and gene therapies from preclinical development to commercialization, addressing manufacturing challenges and improving patient access to advanced therapies.
Cell and Gene Therapy Manufacturing Services Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Cell and Gene Therapy Manufacturing Services market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Cell and Gene Therapy Manufacturing Services survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Cell and Gene Therapy Manufacturing Services industry.
Key market trends defining the global Cell and Gene Therapy Manufacturing Services demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Cell and Gene Therapy Manufacturing Services Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Cell and Gene Therapy Manufacturing Services industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Cell and Gene Therapy Manufacturing Services companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Cell and Gene Therapy Manufacturing Services industry
Leading Cell and Gene Therapy Manufacturing Services companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Cell and Gene Therapy Manufacturing Services companies.
Cell and Gene Therapy Manufacturing Services Market Study- Strategic Analysis Review
The Cell and Gene Therapy Manufacturing Services market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Cell and Gene Therapy Manufacturing Services industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Cell and Gene Therapy Manufacturing Services Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Cell and Gene Therapy Manufacturing Services Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Cell and Gene Therapy Manufacturing Services market segments. Similarly, Strong market demand is encouraging Canadian Cell and Gene Therapy Manufacturing Services companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Cell and Gene Therapy Manufacturing Services market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Cell and Gene Therapy Manufacturing Services Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Cell and Gene Therapy Manufacturing Services industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Cell and Gene Therapy Manufacturing Services market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Cell and Gene Therapy Manufacturing Services in Asia Pacific. In particular, China, India, and South East Asian Cell and Gene Therapy Manufacturing Services markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Cell and Gene Therapy Manufacturing Services Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Cell and Gene Therapy Manufacturing Services market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Cell and Gene Therapy Manufacturing Services.
Cell and Gene Therapy Manufacturing Services Market Company Profiles
The global Cell and Gene Therapy Manufacturing Services market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are ABL Inc, Andelyn Biosciences LLC, Anemocyte Srl, BioCentriq LLC, Catalent Inc, Cell and Gene Therapy Catapult, Charles River Laboratories International Inc, ElevateBio Holdings Inc, FinVector Oy, Forge Biologics Inc, FUJIFILM Holdings Corp, Genezen Laboratories Ltd, JRS Pharma LP, Lonza Group Ltd, Merck KGaA, Nikon Corp, Oxford Biomedica plc, Porton Advanced Solutions Ltd, Resilience Corp, RoslinCT , Takara Bio Inc, The Discovery Labs LLC, Thermo Fisher Scientific Inc, Vibalogics GmbH, WuXi AppTec Co. Ltd.
Recent Cell and Gene Therapy Manufacturing Services Market Developments
The global Cell and Gene Therapy Manufacturing Services market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Cell and Gene Therapy Manufacturing Services Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Cell Therapy
-Allogeneic
-Autologous
-Viral Vector
Gene Therapy
-Viral Vector
-Non-viral Vector
By Indication
Oncology
Cardiovascular
Orthopedic
Ophthalmology
Central Nervous System
Infectious Diseases
Others
By Application
Clinical Manufacturing
Commercial Manufacturing
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Geographical Segmentation:
ABL Inc
Andelyn Biosciences LLC
Anemocyte Srl
BioCentriq LLC
Catalent Inc
Cell and Gene Therapy Catapult
Charles River Laboratories International Inc
ElevateBio Holdings Inc
FinVector Oy
Forge Biologics Inc
FUJIFILM Holdings Corp
Genezen Laboratories Ltd
JRS Pharma LP
Lonza Group Ltd
Merck KGaA
Nikon Corp
Oxford Biomedica plc
Porton Advanced Solutions Ltd
Resilience Corp
RoslinCT
Takara Bio Inc
The Discovery Labs LLC
Thermo Fisher Scientific Inc
Vibalogics GmbH
WuXi AppTec Co. Ltd
Formats Available: Excel, PDF, and PPT
The cell and gene therapy manufacturing services market is driven by the increasing investment in cell and gene therapy development, advancements in bioprocessing technologies, and the need for scalable and cost-effective manufacturing solutions. By 2030, the market is expected to witness significant growth, fueled by innovations in cell expansion systems, viral vector production platforms, and automated manufacturing processes. Further, expanding applications in personalized medicine, rare disease therapies, and cancer immunotherapies are anticipated to drive market expansion, enabling biopharmaceutical companies and contract development and manufacturing organizations (CDMOs) to accelerate the translation of cell and gene therapies from preclinical development to commercialization, addressing manufacturing challenges and improving patient access to advanced therapies.
Cell and Gene Therapy Manufacturing Services Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Cell and Gene Therapy Manufacturing Services market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Cell and Gene Therapy Manufacturing Services survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Cell and Gene Therapy Manufacturing Services industry.
Key market trends defining the global Cell and Gene Therapy Manufacturing Services demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Cell and Gene Therapy Manufacturing Services Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Cell and Gene Therapy Manufacturing Services industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Cell and Gene Therapy Manufacturing Services companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Cell and Gene Therapy Manufacturing Services industry
Leading Cell and Gene Therapy Manufacturing Services companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Cell and Gene Therapy Manufacturing Services companies.
Cell and Gene Therapy Manufacturing Services Market Study- Strategic Analysis Review
The Cell and Gene Therapy Manufacturing Services market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Cell and Gene Therapy Manufacturing Services industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Cell and Gene Therapy Manufacturing Services Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Cell and Gene Therapy Manufacturing Services Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Cell and Gene Therapy Manufacturing Services market segments. Similarly, Strong market demand is encouraging Canadian Cell and Gene Therapy Manufacturing Services companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Cell and Gene Therapy Manufacturing Services market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Cell and Gene Therapy Manufacturing Services Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Cell and Gene Therapy Manufacturing Services industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Cell and Gene Therapy Manufacturing Services market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Cell and Gene Therapy Manufacturing Services in Asia Pacific. In particular, China, India, and South East Asian Cell and Gene Therapy Manufacturing Services markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Cell and Gene Therapy Manufacturing Services Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Cell and Gene Therapy Manufacturing Services market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Cell and Gene Therapy Manufacturing Services.
Cell and Gene Therapy Manufacturing Services Market Company Profiles
The global Cell and Gene Therapy Manufacturing Services market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are ABL Inc, Andelyn Biosciences LLC, Anemocyte Srl, BioCentriq LLC, Catalent Inc, Cell and Gene Therapy Catapult, Charles River Laboratories International Inc, ElevateBio Holdings Inc, FinVector Oy, Forge Biologics Inc, FUJIFILM Holdings Corp, Genezen Laboratories Ltd, JRS Pharma LP, Lonza Group Ltd, Merck KGaA, Nikon Corp, Oxford Biomedica plc, Porton Advanced Solutions Ltd, Resilience Corp, RoslinCT , Takara Bio Inc, The Discovery Labs LLC, Thermo Fisher Scientific Inc, Vibalogics GmbH, WuXi AppTec Co. Ltd.
Recent Cell and Gene Therapy Manufacturing Services Market Developments
The global Cell and Gene Therapy Manufacturing Services market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Cell and Gene Therapy Manufacturing Services Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Cell Therapy
-Allogeneic
-Autologous
-Viral Vector
Gene Therapy
-Viral Vector
-Non-viral Vector
By Indication
Oncology
Cardiovascular
Orthopedic
Ophthalmology
Central Nervous System
Infectious Diseases
Others
By Application
Clinical Manufacturing
Commercial Manufacturing
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
ABL Inc
Andelyn Biosciences LLC
Anemocyte Srl
BioCentriq LLC
Catalent Inc
Cell and Gene Therapy Catapult
Charles River Laboratories International Inc
ElevateBio Holdings Inc
FinVector Oy
Forge Biologics Inc
FUJIFILM Holdings Corp
Genezen Laboratories Ltd
JRS Pharma LP
Lonza Group Ltd
Merck KGaA
Nikon Corp
Oxford Biomedica plc
Porton Advanced Solutions Ltd
Resilience Corp
RoslinCT
Takara Bio Inc
The Discovery Labs LLC
Thermo Fisher Scientific Inc
Vibalogics GmbH
WuXi AppTec Co. Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Cell and Gene Therapy Manufacturing Services Market Overview and Key Findings, 2024
1.2 Cell and Gene Therapy Manufacturing Services Market Size and Growth Outlook, 2021- 2030
1.3 Cell and Gene Therapy Manufacturing Services Market Growth Opportunities to 2030
1.4 Key Cell and Gene Therapy Manufacturing Services Market Trends and Challenges
1.4.1 Cell and Gene Therapy Manufacturing Services Market Drivers and Trends
1.4.2 Cell and Gene Therapy Manufacturing Services Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Cell and Gene Therapy Manufacturing Services Companies
2. CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE OUTLOOK TO 2030
2.1 Cell and Gene Therapy Manufacturing Services Market Size Outlook, USD Million, 2021- 2030
2.2 Cell and Gene Therapy Manufacturing Services Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Cell Therapy
-Allogeneic
-Autologous
-Viral Vector
Gene Therapy
-Viral Vector
-Non-viral Vector
By Indication
Oncology
Cardiovascular
Orthopedic
Ophthalmology
Central Nervous System
Infectious Diseases
Others
By Application
Clinical Manufacturing
Commercial Manufacturing
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Cell and Gene Therapy Manufacturing Services Market, 2025
5.2 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Cell and Gene Therapy Manufacturing Services Market, 2025
5.5 Europe Cell and Gene Therapy Manufacturing Services Market Size Outlook by Type, 2021- 2030
5.6 Europe Cell and Gene Therapy Manufacturing Services Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Cell and Gene Therapy Manufacturing Services Market, 2025
5.8 North America Cell and Gene Therapy Manufacturing Services Market Size Outlook by Type, 2021- 2030
5.9 North America Cell and Gene Therapy Manufacturing Services Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Cell and Gene Therapy Manufacturing Services Market, 2025
5.11 South America Pacific Cell and Gene Therapy Manufacturing Services Market Size Outlook by Type, 2021- 2030
5.12 South America Cell and Gene Therapy Manufacturing Services Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, 2025
5.14 Middle East Africa Cell and Gene Therapy Manufacturing Services Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Cell and Gene Therapy Manufacturing Services Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Cell and Gene Therapy Manufacturing Services Market Size Outlook and Revenue Growth Forecasts
6.2 US Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
7. CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CELL AND GENE THERAPY MANUFACTURING SERVICES COMPANY PROFILES
8.1 Profiles of Leading Cell and Gene Therapy Manufacturing Services Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
ABL Inc
Andelyn Biosciences LLC
Anemocyte Srl
BioCentriq LLC
Catalent Inc
Cell and Gene Therapy Catapult
Charles River Laboratories International Inc
ElevateBio Holdings Inc
FinVector Oy
Forge Biologics Inc
FUJIFILM Holdings Corp
Genezen Laboratories Ltd
JRS Pharma LP
Lonza Group Ltd
Merck KGaA
Nikon Corp
Oxford Biomedica plc
Porton Advanced Solutions Ltd
Resilience Corp
RoslinCT
Takara Bio Inc
The Discovery Labs LLC
Thermo Fisher Scientific Inc
Vibalogics GmbH
WuXi AppTec Co. Ltd.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Cell and Gene Therapy Manufacturing Services Market Overview and Key Findings, 2024
1.2 Cell and Gene Therapy Manufacturing Services Market Size and Growth Outlook, 2021- 2030
1.3 Cell and Gene Therapy Manufacturing Services Market Growth Opportunities to 2030
1.4 Key Cell and Gene Therapy Manufacturing Services Market Trends and Challenges
1.4.1 Cell and Gene Therapy Manufacturing Services Market Drivers and Trends
1.4.2 Cell and Gene Therapy Manufacturing Services Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Cell and Gene Therapy Manufacturing Services Companies
2. CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE OUTLOOK TO 2030
2.1 Cell and Gene Therapy Manufacturing Services Market Size Outlook, USD Million, 2021- 2030
2.2 Cell and Gene Therapy Manufacturing Services Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Cell Therapy
-Allogeneic
-Autologous
-Viral Vector
Gene Therapy
-Viral Vector
-Non-viral Vector
By Indication
Oncology
Cardiovascular
Orthopedic
Ophthalmology
Central Nervous System
Infectious Diseases
Others
By Application
Clinical Manufacturing
Commercial Manufacturing
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Cell and Gene Therapy Manufacturing Services Market, 2025
5.2 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Cell and Gene Therapy Manufacturing Services Market, 2025
5.5 Europe Cell and Gene Therapy Manufacturing Services Market Size Outlook by Type, 2021- 2030
5.6 Europe Cell and Gene Therapy Manufacturing Services Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Cell and Gene Therapy Manufacturing Services Market, 2025
5.8 North America Cell and Gene Therapy Manufacturing Services Market Size Outlook by Type, 2021- 2030
5.9 North America Cell and Gene Therapy Manufacturing Services Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Cell and Gene Therapy Manufacturing Services Market, 2025
5.11 South America Pacific Cell and Gene Therapy Manufacturing Services Market Size Outlook by Type, 2021- 2030
5.12 South America Cell and Gene Therapy Manufacturing Services Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, 2025
5.14 Middle East Africa Cell and Gene Therapy Manufacturing Services Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Cell and Gene Therapy Manufacturing Services Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Cell and Gene Therapy Manufacturing Services Market Size Outlook and Revenue Growth Forecasts
6.2 US Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Cell and Gene Therapy Manufacturing Services Industry Drivers and Opportunities
7. CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CELL AND GENE THERAPY MANUFACTURING SERVICES COMPANY PROFILES
8.1 Profiles of Leading Cell and Gene Therapy Manufacturing Services Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
ABL Inc
Andelyn Biosciences LLC
Anemocyte Srl
BioCentriq LLC
Catalent Inc
Cell and Gene Therapy Catapult
Charles River Laboratories International Inc
ElevateBio Holdings Inc
FinVector Oy
Forge Biologics Inc
FUJIFILM Holdings Corp
Genezen Laboratories Ltd
JRS Pharma LP
Lonza Group Ltd
Merck KGaA
Nikon Corp
Oxford Biomedica plc
Porton Advanced Solutions Ltd
Resilience Corp
RoslinCT
Takara Bio Inc
The Discovery Labs LLC
Thermo Fisher Scientific Inc
Vibalogics GmbH
WuXi AppTec Co. Ltd.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
